Literature DB >> 6191505

Treatment of the ichthyosis of the Sjögren-Larsson syndrome with etretinate (Tigason).

S Jagell, S Lidén.   

Abstract

The ichthyosis of seven patients with the Sjögren-Larsson syndrome was treated with an aromatic retinoid, etretinate, during six months. Very good results were registered in six of the patients measured both as clinical improvement and as reduction in quantity of emollients needed. No unexpected side effects were noted.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6191505

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


  5 in total

1.  The Sjogren-Larsson syndrome in a north Indian sibship.

Authors:  B K Thakur; E H Smith
Journal:  Indian J Pediatr       Date:  1991 Jan-Feb       Impact factor: 1.967

Review 2.  Etretinate therapy in children with severe keratinization defects.

Authors:  H Traupe; R Happle
Journal:  Eur J Pediatr       Date:  1985-01       Impact factor: 3.183

3.  Sjogren-Larsson syndrome.

Authors:  Meena Sood; Amita Trehan; J Dinakaran; R K Marwaha
Journal:  Indian J Pediatr       Date:  2002-02       Impact factor: 1.967

4.  Genetics and prospective therapeutic targets for Sjögren-Larsson Syndrome.

Authors:  William B Rizzo
Journal:  Expert Opin Orphan Drugs       Date:  2016-03-10       Impact factor: 0.694

5.  Consensus recommendations for the use of retinoids in ichthyosis and other disorders of cornification in children and adolescents.

Authors:  Andrea L Zaenglein; Moise L Levy; Nicole S Stefanko; Latanya T Benjamin; Anna L Bruckner; Keith Choate; Brittany G Craiglow; John J DiGiovanna; Lawrence F Eichenfield; Peter Elias; Philip Fleckman; Leslie P Lawley; Richard A Lewis; Anne W Lucky; Erin F Mathes; Leonard M Milstone; Amy S Paller; Sonali S Patel; Dawn H Siegel; Joyce Teng; Sherry A Tanumihardjo; Lauren Thaxton; Mary L Williams
Journal:  Pediatr Dermatol       Date:  2020-11-10       Impact factor: 1.588
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.